Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Government announcement on investment into neurodegenerative disease research of 14 November 2021, what (a) allocation of funding is available for research into cures for Parkinson's Disease and (b) the allocation process is to determine the distribution of funds.

The £375 million investment will fund research projects into a range of neurodegenerative diseases, including Parkinson’s disease, through the National Institute for Health Research (NIHR) and UK Research and Innovation (UKRI). The NIHR and UKRI rely on researchers submitting high-quality applications to access funding, therefore details of allocations are not currently available. All applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality.